Page last updated: 2024-12-06

tungstate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Tungstates are a class of inorganic compounds that contain the tungstate anion (WO42−). They are generally formed by the reaction of a metal oxide with tungsten trioxide (WO3) at high temperatures. Tungstates are known for their diverse applications, including their use in pigments, catalysts, phosphors, and scintillation materials. Their unique properties, such as their high refractive index, high density, and good electrical conductivity, have led to their widespread use in various industries. The study of tungstates is important because they exhibit interesting optical, electronic, and magnetic properties, making them promising candidates for advanced materials applications.'

Cross-References

ID SourceID
PubMed CID24465
CHEMBL ID85943
CHEBI ID46502
MeSH IDM0133370

Synonyms (24)

Synonym
CHEMBL85943 ,
tungsten (vi) tetraoxide
wo4(2-)
tungstate ion
51682-10-1
TUNGSTATE ,
wolframate
tungstate(vi)ion
tetraoxidotungstate(vi)
[wo4](2-)
tetraoxidotungstate(2-)
wolframat
CHEBI:46502
14311-52-5
bdbm50080994
dioxido(dioxo)tungsten
tungstate (w12(oh)2o4010-)
tungstate, (188)w-labeled; tungstate, w-o4(2-)
sw0y0wq46i ,
unii-sw0y0wq46i
12737-86-9
PBYZMCDFOULPGH-UHFFFAOYSA-N
Q27104569
tungstate (wo42-),(t-4)- (9ci)

Research Excerpts

Overview

Tungstate is a powerful antidiabetic agent. It has been shown to promote β-cell recovery in toxin-induced diabetic rodent models.

ExcerptReferenceRelevance
"Tungstate is a powerful antidiabetic agent that has been shown to promote β-cell recovery in toxin-induced diabetic rodent models."( Tungstate promotes β-cell survival in Irs2-/- mice.
Burks, DJ; Garcia, A; Gasa, R; Gomis, R; Guinovart, JJ; Kalko, SG; Oliveira, JM; Rebuffat, SA; Zafra, D, 2014
)
2.57

Treatment

Tungstate treatment restored the number and function of immune cells as well as the immunoglobulin level in diabetic rats. Tungstate also restored pyruvate kinase activity and fructose 2,6-bisphosphate concentrations.

ExcerptReferenceRelevance
"Tungstate treatment increased extra-islet beta-cell replication without modifying intra-islet beta-cell replication rates."( Stable and functional regeneration of pancreatic beta-cell population in nSTZ-rats treated with tungstate.
Barberà, A; Barceló-Batllori, S; Claret, M; Fernández-Alvarez, J; Gomis, R; Guinovart, JJ; Nadal, B; Piquer, S, 2004
)
1.26
"Tungstate treatment induced phosphorylation and subsequent activation of p38 and PI3K which in turn are implicated in tungstate PDX-1 nuclear localization and activation."( Phosphorylation events implicating p38 and PI3K mediate tungstate-effects in MIN6 beta cells.
Barceló-Batllori, S; Gomis, R; Guinovart, JJ; Julià, M; Marzo, N; Nadal, B; Piquer, S, 2007
)
1.31
"Tungstate treatment of these rats induced a 42% decrease in serum levels of triglycerides and normalized hepatic G6P concentrations, GPa activity, and PEPCK levels."( Effects of tungstate, a new potential oral antidiabetic agent, in Zucker diabetic fatty rats.
Barberà, A; Domínguez, J; Fernàndez-Alvarez, J; Gomis, R; Guinovart, JJ; Muñoz, MC, 2001
)
1.42
"Tungstate treatment also restored pyruvate kinase activity and fructose 2,6-bisphosphate concentrations."( Tungstate is an effective antidiabetic agent in streptozotocin-induced diabetic rats: a long-term study.
Barberà, A; Domingo, M; Gomis, R; Gomis, RR; Guinovart, JJ; Prats, N; Rodríguez-Gil, JE, 2001
)
2.47
"Tungstate treatment restored the number and function of immune cells as well as the immunoglobulin level in STZ diabetic rats."( Immunomodulatory effect of tungstate on streptozotocin-induced experimental diabetes in rats.
Palanivel, R; Sakthisekaran, D, 2002
)
1.33

Toxicity

ExcerptReferenceRelevance
" LD50 values for 1-14 days show that sodium metatungstate is significantly more toxic to fish than sodium tungstate."( Tungsten speciation and toxicity: acute toxicity of mono- and poly-tungstates to fish.
Christodoulatos, C; Koutsospyros, A; Strigul, N, 2010
)
0.85

Dosage Studied

ExcerptRelevanceReference
" Results showed that Pb was absorbed in a dose-response manner in blood, tissues, and feathers, and erythrocyte protoporphyrin, a biomarker of early Pb effect, was increased at blood Pb levels >50 μg/dL."( Lead and copper in pigeons (Columbia livia) exposed to a small arms-range soil.
Bannon, DI; Centeno, JA; Dennis, WE; Johnson, MS; Lal, S; Parsons, PJ; Rosencrance, AB; Xu, H, 2011
)
0.37
" Dose-response inhibitor experiments were conducted with a number of SRM isolates and enrichments at 30-80 °C and an increase in the effectiveness of tungstate treatment at higher temperatures was observed."( Tungstate Control of Microbial Sulfidogenesis and Souring of the Engineered Environment.
Carlson, HK; Coates, JD; Engelbrektson, AL; Huang, LL; Kumar, A; Liu, Y; Menon, AR; Thieme, J; Williamson, AJ, 2020
)
2.2
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
tungsten oxoanion
divalent inorganic anionAny inorganic anion with a valency of two.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (9)

PathwayProteinsCompounds
methanol oxidation to carbon dioxide414
superpathway of glycolysis, pyruvate dehydrogenase, TCA, and glyoxylate bypass3989
TCA cycle I (prokaryotic)1741
molybdenum cofactor biosynthesis1823
nitrite oxidation411
mixed acid fermentation3276
phytate degradation I021
nicotine degradation I (pyridine pathway)1341
superpathway of glyoxylate bypass and TCA1855

Research

Studies (337)

TimeframeStudies, This Drug (%)All Drugs %
pre-199028 (8.31)18.7374
1990's65 (19.29)18.2507
2000's97 (28.78)29.6817
2010's116 (34.42)24.3611
2020's31 (9.20)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 56.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index56.93 (24.57)
Research Supply Index5.84 (2.92)
Research Growth Index4.87 (4.65)
Search Engine Demand Index93.94 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (56.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (0.88%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other339 (99.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]